Article10.231/jim.0b013e3181cf91ca
Adipokines in patients with cancer anorexia and cachexia.
Joanna Smiechowska,Anne Utech,George E. Taffet,Teresa G. Hayes,Marco Marcelli,José M. Garcia-2010-03-01-PubMed
61
TL;DRAbstract
Leptin may play a role in the increased insulin resistance seen in cancer patients. However, these patients are resistant to the orexigenic effects of hypoleptinemia. Other mechanisms besides weight loss are responsible for the increased adiponectin level seen in cancer patients. It is unlikely that resistin plays a major metabolic role in this setting.
Chat with Paper
AI Agents for this Paper
Leptin may play a role in the increased insulin resistance seen in cancer patients. However, these patients are resistant to the orexigenic effects of hypoleptinemia. Other mechanisms besides weight loss are responsible for the increased adiponectin level seen in cancer patients. It is unlikely that resistin plays a major metabolic role in this setting.
Keywords
ResistinCachexiaInternal medicineEndocrinologyInsulin resistanceLeptinAdipokineMedicine
Chat
Click to start Chat